References
- Mastrangelo R, Riccardi R, Corbo S, Marchetti P, Iacobelli S. Prediction of clinical response to glucocorticoids in children with acute lymphoblastic leukemia. Eur Paediatr Haematol Oncol. 1984; 1: 33–36
- Mastrangelo R, Lasorella A, Riccardi R. Carboplatin in childhood medulloblastoma/PNET: Feasibility of an in vivo sensitivity test in an “up front” study. Med Pediatr Oncol. 1995; 24: 188–196
- Mastrangelo R, Tornesello A, Riccardi R. A new approach in the treatment of stage IV neuroblastoma using a combination of 131-meta-iodobenzylguanidine (MIBG) and cisplatin. Eur J Cancer 1995; 31A: 606–611
- Iacobelli S, Ranelletti F O, Longo P, Riccardi R, Mastrangelo R. Discrepancies between in vivo and in vitro effects of glucocorticoids in myelomonocytic leukemic cells with steroid receptors. Cancer Res 1978; 38: 4257–4262
- Mastrangelo R, Malandrino R, Riccardi R, Longo P, Ranelletti F O, Iacobelli S. Clinical implications of glucocorticoid receptor studies in childhood acute lymphoblastic leukemia. Blood 1980; 56: 1036–1040
- Riccardi R, Balis F, Ferrara P, Lasorella A, Poplack D, Mastrangelo R. Influence of food intake on bioavailability of oral 6-mercaptopurine in children with acute lymphoblastic leukemia. Pediatr Hematol Oncol 1986; 3: 319–324
- Riccardi R, Riccardi A, Lasorella A. Clinical pharmacokinetics of carboplatin in children. Cancer Chemother Pharmacol. 1994; 33: 477–483
- Riccardi R, Riccardi A, Di Rocco C. Cerebrospinal fluid pharmacokinetics of carboplatin in children with brain tumors. Cancer Chemother Pharmacol. 1992; 30: 21–24
- Iavarone A, Lasorella A, Servidei T, Riccardi R, Mastrangelo R. Uptake and storage of metaiodo-benzylguanidine are frequent neuronal functions of human neuroblastoma cell lines. Cancer Res 1993; 53: 304–309